A recently published study indicating the anti-parasitic ivermectin worked well as a prophylactic against the virus that causes COVID-19 should help sway critics of the drug, according to Dr. Pierre Kory, president of the Front Line COVID-19 Critical Care Alliance (FLCCC). “That should convince any naysayer,” Kory told The Epoch Times’ “American Thought Leaders.” “What they found was astounding.” The Brazilian city of Itajaí launched a program that gave ivermectin to any residents that wanted any. The period that was studied was from July 7, 2020, to December 2, 2020. Researchers found that the program, which had over 100,000 residents participate, was linked to a 44 percent drop in COVID-19 cases. Approximately 3.7 percent of ivermectin users contracted the illness during the trial period, compared to 6.6 percent of residents who didn’t take the drug. The program was also associated with a statistically significant decrease in hospitalization and mortality. The …